Matthew Reber

Partnerat 1315 Capital· PA
Current roles
1
Investments attributed
2
Board seats
2
Form D directors and board-seat deals
More
Ask DFX about thisView relationshipsFind contactsInvestmentsBoard seats
As of · this person's identity; each section below carries its own date

1 verified contact (1 professional url)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. Current
    role

    Partner at 1315 Capital.

    Tenure says how settled this partner is at the firm.

    FactForm ADV Schedule A and the firm's team pageFor Founders, LPsRoles →
Drawing the relationship network…

Roles

1 current, 0 past

Investments attributed to this person

2
CompanyRoundInvestorAttributionDateSource
Experic, LLCForm D equity offering · $10.0M1315 Capitalstrongly supported · boardSep 25, 2024Inference sec.gov
Primrose Bio, Inc.Form D equity offering · $15.0M1315 Capitalstrongly supported · boardJul 17, 2024Inference sec.gov

Board seats and vehicles

2 boards, 0 vehicles

Timeline

2 dated entries: events, attributed deals, board seats and role changes
  1. Sep 25, 2024
    Form D equity offering in Experic, LLC (1315 Capital)
    Attributed investment Inference Experic, LLC Form D
  2. Jul 17, 2024
    Form D equity offering in Primrose Bio, Inc. (1315 Capital)
    Attributed investment Inference Primrose Bio, Inc. Form D

Relationships across DFX

on 1 other DFX graph
Across the graphs

Matthew Reber is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…